Premium
Percutanous management of tricuspid regurgitation: The “ A chilles tendon” of transcatheter valve interventions
Author(s) -
Cilingiroglu Mehmet,
Marmagkiolis Konstantinos
Publication year - 2016
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.26665
Subject(s) - medicine , regurgitation (circulation) , tricuspid valve , inferior vena cava , cardiology , tricuspid insufficiency , tricuspid valve insufficiency , surgery
Key Points Moderate‐to‐severe tricuspid insufficiency affects 1.6 million patients in the USA, resulting in increased morbidity and mortality and without safe and effective medical or surgical treatment options. The unique tricuspid valve anatomy, the presence of immediate adjacent anatomic landmarks at risk and the decreased blood pressure of flow complicate the development of effective transcatheter strategies. The HOVER trial will assess the safety and effectiveness of the CAVI approach with implantation of the Edwards, Sapien XT in the inferior vena cava.